Combined SPIO-gadolinium magnetic resonance imaging in cirrhotic patients: Negative predictive value and role in screening for hepatocellular carcinoma

Abdominal Imaging

Volumn 33, Issue 5, 2008, Pages 520-528

  Guiu, Boris ^a   Loffroy, Romaric ^a   Ben Salem, Douraied ^a   Lepage, Come ^a   Guiu, Séverine ^b   Aho, Serge ^a   Jouve, Jean Louis ^a   Krausé, Denis ^a   Cercueil, Jean Pierre ^a  

^a HÔPITAL DU BOCAGE   (France)

^b CENTRE GEORGES FRANÇOIS LECLERC   (France)

Author keywords

Double contrast imaging; Hepatocellular carcinoma; Liver cirrhosis; Liver specific MRI; SPIO

Indexed keywords

CONTRAST MEDIUM; GADODIAMIDE; SUPERPARAMAGNETIC IRON OXIDE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; CONTRAST ENHANCEMENT; DIAGNOSTIC IMAGING; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER NODULE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; RADIOLOGIST; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IRON; LIVER CIRRHOSIS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OXIDES; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES;

EID: 48249098307     PISSN: 09428925     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00261-007-9327-9     Document Type: Article

References (49)

1. MR Arguedas 2003 Screening for hepatocellular carcinoma: why, when, how? Curr Gastroenterol Rep 5 57 62
2. M Sherman 2005 Screening for hepatocellular carcinoma Best Pract Res Clin Gastroenterol 19 101 118
3. J Bruix M Sherman JM Llovet 2001 Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European association for the study of the liver J Hepatol 35 421 430
4. B Bhartia J Ward JA Guthrie 2003 Hepatocellular carcinoma in cirrhotic livers: double-contrast thin-section MR imaging with pathologic correlation of explanted tissue AJR Am J Roentgenol 180 577 584
5. J Halavaara P Tervahartiala H Isoniemi 2002 Efficacy of sequential use of superparamagnetic iron oxide and gadolinium in liver MR imaging Acta Radiol 43 180 185
6. S Kubaska DV Sahani S Saini 2001 Dual contrast enhanced magnetic resonance imaging of the liver with superparamagnetic iron oxide followed by gadolinium for lesion detection and characterization Clin Radiol 56 410 415
7. J Ward JA Guthrie DJ Scott 2000 Hepatocellular carcinoma in the cirrhotic liver: double-contrast MR imaging for diagnosis Radiology 216 154 162
8. J Ward PJ Robinson 2001 Combined use of MR contrast agents for evaluating liver disease Magn Reson Imaging Clin North Am 9 767 802
9. G Jung J Breuer LW Poll 2006 Imaging characteristics of hepatocellular carcinoma using the hepatobiliary contrast agent Gd-EOB-DTPA Acta Radiol 47 15 23
10. YK Kim HS Kwak CS Kim 2006 Hepatocellular carcinoma in patients with chronic liver disease: comparison of SPIO-enhanced MR imaging and 16-detector row CT Radiology 238 531 541
11. G Jung L Poll M Cohnen 2005 Differential diagnosis of focal liver lesions using contrast-enhanced MRI with SHU 555 A in comparison with unenhanced MRI and multidetector spiral-CT ROFO 177 1571 1577
12. A Colli M Fraquelli G Casazza 2006 Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review Am J Gastroenterol 101 513 523
13. MC Castoldi V Fauda D Scaramuzza 2000 Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media Radiol Med (Torino) 100 160 167
14. V de Ledinghen D Laharie R Lecesne 2002 Detection of nodules in liver cirrhosis: spiral computed tomography or magnetic resonance imaging? A prospective study of 88 nodules in 34 patients Eur J Gastroenterol Hepatol 14 159 165
15. AE Holland EM Hecht WY Hahn 2005 Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver Radiology 237 938 944
16. BK Kang JH Lim SH Kim 2003 Preoperative depiction of hepatocellular carcinoma: ferumoxides-enhanced MR imaging versus triple-phase helical CT Radiology 226 79 85
17. YK Kim CS Kim YH Lee 2004 Comparison of superparamagnetic iron oxide-enhanced and gadobenate dimeglumine-enhanced dynamic MRI for detection of small hepatocellular carcinomas AJR Am J Roentgenol 182 1217 1223
18. L Libbrecht D Bielen C Verslype 2002 Focal lesions in cirrhotic explant livers: pathological evaluation and accuracy of pretransplantation imaging examinations Liver Transpl 8 749 761
19. AM Lutz JK Willmann K Goepfert 2005 Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging Radiology 237 520 528
20. K Mori J Scheidler T Helmberger 2002 Detection of malignant hepatic lesions before orthotopic liver transplantation: accuracy of ferumoxides-enhanced MR imaging AJR Am J Roentgenol 179 1045 1051
21. JH Youk JM Lee CS Kim 2004 MRI for detection of hepatocellular carcinoma: comparison of mangafodipir trisodium and gadopentetate dimeglumine contrast agents AJR Am J Roentgenol 183 1049 1054
22. NM Rofsky JC Weinreb ME Bernardino 1993 Hepatocellular tumors: characterization with Mn-DPDP-enhanced MR imaging Radiology 188 53 59
23. YY Jeong DG Mitchell T Kamishima 2002 Small (<20 mm) enhancing hepatic nodules seen on arterial phase MR imaging of the cirrhotic liver: clinical implications AJR Am J Roentgenol 178 1327 1334
24. JA Talwalkar GJ Gores 2004 Diagnosis and staging of hepatocellular carcinoma Gastroenterology 127 S126 S132
25. M Colombo 1999 Natural history and pathogenesis of hepatitis C virus related hepatocellular carcinoma J Hepatol 31 Suppl 1 25 30
26. J Cohen 1960 A coefficient of agreement for nominal scales Educ Psychol Meas 20 37 46
27. D Pouliquen JJ Le Jeune R Perdrisot 1991 Iron oxide nanoparticles for use as an MRI contrast agent: pharmacokinetics and metabolism Magn Reson Imaging 9 275 283
28. A Tanimoto Y Yuasa H Shinmoto 2002 Superparamagnetic iron oxide-mediated hepatic signal intensity change in patients with and without cirrhosis: pulse sequence effects and Kupffer cell function Radiology 222 661 666
29. DA Aguirre CA Behling E Alpert 2006 Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging Radiology 239 425 437
30. J Ward PJ Robinson 2002 How to detect hepatocellular carcinoma in cirrhosis Eur Radiol 12 2258 2272
31. S Suzuki H Iijima F Moriyasu 2004 Differential diagnosis of hepatic nodules using delayed parenchymal phase imaging of levovist contrast ultrasound: comparative study with SPIO-MRI Hepatol Res 29 122 126
32. Y Asahina N Izumi M Uchihara 2003 Assessment of Kupffer cells by ferumoxides-enhanced MR imaging is beneficial for diagnosis of hepatocellular carcinoma: comparison of pathological diagnosis and perfusion patterns assessed by CT hepatic arteriography and CT arterioportography Hepatol Res 27 196 204
33. Y Imai T Murakami S Yoshida 2000 Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading Hepatology 32 205 212
34. O Lucidarme F Baleston M Cadi 2003 Non-invasive detection of liver fibrosis: is superparamagnetic iron oxide particle-enhanced MR imaging a contributive technique? Eur Radiol 13 467 474
35. P Heim P Steiner V Schoder 2003 Detection of liver lesions with gadolinium-enhanced VIBE sequence in comparison with SPIO-enhanced MRI ROFO 175 1376 1383
36. MJ Kim JH Kim JJ Chung 2003 Focal hepatic lesions: detection and characterization with combination gadolinium- and superparamagnetic iron oxide-enhanced MR imaging Radiology 228 719 726
37. A Tanimoto Y Satoh Y Yuasa 1997 Performance of Gd-EOB-DTPA and superparamagnetic iron oxide particles in the detection of primary liver cancer: a comparative study by alternative free-response receiver operating characteristic analysis J Magn Reson Imaging 7 120 124
38. K Takahama Y Amano H Hayashi 2003 Detection and characterization of focal liver lesions using superparamagnetic iron oxide-enhanced magnetic resonance imaging: comparison between ferumoxides-enhanced T1-weighted imaging and delayed-phase gadolinium-enhanced T1-weighted imaging Abdom Imaging 28 525 530
39. M Matsuo M Kanematsu K Itoh 2001 Detection of malignant hepatic tumors: comparison of gadolinium-and ferumoxide-enhanced MR imaging AJR Am J Roentgenol 177 637 643
40. G Simon TM Link K Wortler 2005 Detection of hepatocellular carcinoma: comparison of Gd-DTPA- and ferumoxides-enhanced MR imaging Eur Radiol 15 895 903
41. A Tanimoto G Wakabayashi H Shinmoto 2005 Superparamagnetic iron oxide-enhanced MR imaging for focal hepatic lesions: a comparison with CT during arterioportography plus CT during hepatic arteriography J Gastroenterol 40 371 380
42. M Hori T Murakami T Kim 2002 Detection of hypervascular hepatocellular carcinoma: comparison of SPIO-enhanced MRI with dynamic helical CT J Comput Assist Tomogr 26 701 710
43. HS Kwak JM Lee CS Kim 2004 Preoperative detection of hepatocellular carcinoma: comparison of combined contrast-enhanced MR imaging and combined CT during arterial portography and CT hepatic arteriography Eur Radiol 14 447 457
44. A Qayyum RF Thoeni FV Coakley 2006 Detection of hepatocellular carcinoma by ferumoxides-enhanced MR imaging in cirrhosis: incremental value of dynamic gadolinium-enhancement J Magn Reson Imaging 23 17 22
45. M Matsuo M Kanematsu H Kondo 2001 Confluent hepatic fibrosis in cirrhosis: ferumoxides-enhanced MR imaging findings Abdom Imaging 26 146 148
46. Y Itai O Matsui 1997 Blood flow and liver imaging Radiology 202 306 314
47. K Mori H Yoshioka Y Itai 2000 Arterioportal shunts in cirrhotic patients: evaluation of the difference between tumorous and nontumorous arterioportal shunts on MR imaging with superparamagnetic iron oxide AJR Am J Roentgenol 175 1659 1664
48. TU Shah RC Semelka E Pamuklar 2006 The risk of hepatocellular carcinoma in cirrhotic patients with small liver nodules on MRI Am J Gastroenterol 101 533 540
49. A Sangiovanni E Del Ninno P Fasani 2004 Increased survival of cirrhotic patients with a hepatocellular carcinoma detected during surveillance Gastroenterology 126 1005 1014